Evidence map›Paper›PMID 39964630›Full record

ReviewEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2025

Septic arthritis - symptoms, diagnosis and new therapy.

Angelika Domagała, Barbara Macura, Karolina Piekarz, Aneta Kiecka

Abstract readReview
PubMed Publisher
In one paragraph

Review in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Angelika DomagałaDepartment of Immunology, Jagiellonian University Medical College, Kraków, Poland.ORCID http://orcid.org/0000-0001-6067-1074
Barbara MacuraFaculty of Health Sciences, Institute of Physiotherapy, Chair of Biomedical Sciences, Jagiellonian University Medical College, Kopernika 7a, Kraków, 31- 034, Poland.ORCID http://orcid.org/0000-0002-5388-6517
Karolina PiekarzCentre of Microbiological Research and Autovaccines, Kraków, Poland.ORCID http://orcid.org/0009-0007-7102-4615
Aneta KieckaCentre of Microbiological Research and Autovaccines, Kraków, Poland. aneta.kiecka@uj.edu.pl.ORCID http://orcid.org/0000-0002-3818-8972

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Septic arthritis (SA) is an infection of one or more joints caused mainly by Staphylococcus aureus, to a lesser extent by streptococci and Gram-negative bacilli. It poses a huge medical problem due to its high mortality rate of 2-15%. Disease symptoms are often vague, resulting in a risk that SA may be diagnosed too late. This shows the urgency of finding a rapid diagnostic method for SA and an effective therapy. Basic treatment of SA including joint drain or empirical antimicrobial therapy does not always provide the desired results. Hence, new therapies are being sought, including the use of antimicrobial peptide or phage therapy.

Indexed as

Arthritis, InfectiousStaphylococcal InfectionsAnti-Bacterial AgentsHumansPhage TherapyStaphylococcus aureusAnti-Bacterial AgentsBacterial arthritisDiagnosticsSeptic arthritisTreatmentVirulence factor

Identifiers

PMID39964630

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.